CardioSignal

0
CardioSignal
CardioSignal is an Android app from Precordior Oy in the Medical category, currently rated — across few ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Medical app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱MVP baseline (design + 1-store ship) | +$28K |
| 📱5 unique screens × $4.5K | +$22K |
| 💎In-app purchase plumbing | +$9K |
| ⚙Medical complexity ×1.55 | +$32K |
| 🌐Cross-platform reach (iOS + Android) | +$50K |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 🏷Category context | Medical |
| 📦Compact Android bundle | → Native Kotlin |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Pre-traction · 39/100INDIE TIERlimited signal- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 2.4★ across 132 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- CardioSignal
- Developer
- Precordior Oy
- Bundle ID
- com.precordior.cardiosignal
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- cardiosignal.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $227/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $6.49 - $41.99 per item
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
CardioSignal application is a reliable and easy-to-use CE marked (Class IIb) medical device. The intended purpose of the application is to detect signs of atrial fibrillation in adults (aged 18 years and older).
Why use CardioSignal:
Atrial fibrillation is the most common heart rhythm disorder, and it may present without symptoms. With regular monitoring, it can be detected and treated early. When left untreated, atrial fibrillation can expose to e.g. stroke and heart failure.
How it works:… View full description on the official store →
Tech & Domain Intel — cardiosignal.com
- Mail provider
- Microsoft 365
- Tech stack
- Apple Pay / Sign in with Apple · Google Workspace · SendGrid
Track this app’s revenue
FREE📝 Description
95
Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
CardioSignal is a very early-stage Android app in the medical space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.



